Evidence map›Paper›PMID 30719430›Full record

ArticleFrontiers in pediatrics2018

Failing to Make Ends Meet: The Broad Clinical Spectrum of DNA Ligase IV Deficiency. Case Series and Review of the Literature.

Aidé Tamara Staines Boone, Ivan K Chinn, Carmen Alaez-Versón, Marco A Yamazaki-Nakashimada, Karol Carrillo-Sánchez, María de la Luz Hortensia García-Cruz, M Cecilia Poli, M Edith González Serrano, Edgar A Medina Torres, David Muzquiz Zermeño and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pediatrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Critical DNA damaging pathways in tumorigenesis.Seminars in cancer biology · 2022
    Review
  11. Inborn errors of immunity caused by defects in the DNA damage response pathways: Importance of minimizing treatment-related genotoxicity.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Aidé Tamara Staines BooneImmunology Department at Hospital de Especialidades, UMAE 25 IMSS, Monterrey, Mexico.
Ivan K ChinnCenter for Human Immunobiology, Texas Children's Hospital, Houston, TX, United States.
Carmen Alaez-VersónGenomic Diagnostic Laboratory at the National Institute for Genomic Medicine (INMEGEN), Mexico City, Mexico.
Marco A Yamazaki-NakashimadaClinical Immunology Department, National Institute of Pediatrics, Mexico City, Mexico.
Karol Carrillo-SánchezGenomic Diagnostic Laboratory at the National Institute for Genomic Medicine (INMEGEN), Mexico City, Mexico.
María de la Luz Hortensia García-CruzOtolaryngology Department at the National Institute of Respiratory Diseases (INER), Mexico City, Mexico.
M Cecilia PoliCenter for Human Immunobiology, Texas Children's Hospital, Houston, TX, United States.
M Edith González SerranoImmunodeficiencies Research Unit at the National Institute of Pediatrics (INP), Mexico City, Mexico.
Edgar A Medina TorresImmunodeficiencies Research Unit at the National Institute of Pediatrics (INP), Mexico City, Mexico.
David Muzquiz ZermeñoImmunology Department at Hospital de Especialidades, UMAE 25 IMSS, Monterrey, Mexico.
Lisa R ForbesCenter for Human Immunobiology, Texas Children's Hospital, Houston, TX, United States.
Francisco J Espinosa-RosalesImmunodeficiencies Research Unit at the National Institute of Pediatrics (INP), Mexico City, Mexico.
Sara E Espinosa-PadillaImmunodeficiencies Research Unit at the National Institute of Pediatrics (INP), Mexico City, Mexico.
Jordan S OrangeCenter for Human Immunobiology, Texas Children's Hospital, Houston, TX, United States.
Saul Oswaldo Lugo ReyesImmunodeficiencies Research Unit at the National Institute of Pediatrics (INP), Mexico City, Mexico.
Hospital de Especialidades · MXNational Institute of Genomic Medicine · MXBaylor College of Medicine · USColumbia University · USTexas Children's Hospital · USUniversidad del Desarrollo · CL

Funding

Baylor-Johns Hopkins Center for Mendelian GeneticsUM1HG006542 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2016 to 2020
$14.5M
NHGRI NIH HHS UM1 HG006542
6 · The paper itself

Abstract

DNA repair defects are inborn errors of immunity that result in increased apoptosis and oncogenesis. DNA Ligase 4-deficient patients suffer from a wide range of clinical manifestations since early in life, including: microcephaly, dysmorphic facial features, growth failure, developmental delay, mental retardation; hip dysplasia, and other skeletal malformations; as well as a severe combined immunodeficiency, radiosensitivity, and progressive bone marrow failure; or, they may present later in life with hematological neoplasias that respond catastrophically to chemo- and radiotherapy; or, they could be asymptomatic. We describe the clinical, laboratory, and genetic features of five Mexican patients with LIG4 deficiency, together with a review of 36 other patients available in PubMed Medline. Four out of five of our patients are dead from lymphoma or bone marrow failure, with severe infection and massive bleeding; the fifth patient is asymptomatic despite a persistent CD4+ lymphopenia. Most patients reported in the literature are microcephalic females with growth failure, sinopulmonary infections, hypogammaglobulinemia, very low B-cells, and radiosensitivity; while bone marrow failure and malignancy may develop at a later age. Dysmorphic facial features, congenital hip dysplasia, chronic liver disease, gradual pancytopenia, lymphoma or leukemia, thrombocytopenia, and gastrointestinal bleeding have been reported as well. Most mutations are compound heterozygous, and all of them are hypomorphic, with two common truncating mutations accounting for the majority of patients. Stem-cell transplantation after reduced intensity conditioning regimes may be curative.

Indexed as

case seriesclinical spectrumDNA repair defectsinborn error of immunityligase IV deficiencyprimary immunodeficiency

Identifiers

PMID30719430
PMCPMC6348249
OpenAlexW2914442720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.